Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Dayforce Inc DAY |
T. Rowe Price Associates, Inc. | 21,691,635 14.100% |
-1,721,384 (-7.35%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Toast, Inc. TOST |
T. Rowe Price Associates, Inc. | 26,766,711 8.000% |
7,622 (+0.03%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
T. Rowe Price Associates, Inc. | 5,064,744 9.200% |
-803,894 (-13.70%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Allbirds, Inc. BIRD |
T. Rowe Price Associates, Inc. | 847 0.000% |
-175,112 (-99.52%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Kodiak Sciences Inc. KOD |
T. Rowe Price Associates, Inc. | 472,013 0.900% |
-2,213,734 (-82.43%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
T. Rowe Price Associates, Inc. | 1,663,528 3.500% |
-1,037,997 (-38.42%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Phreesia, Inc. PHR |
T. Rowe Price Associates, Inc. | 180,384 0.300% |
-3,271,317 (-94.77%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,364,887 9.900% |
-582,798 (-14.76%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | IGM Biosciences, Inc. IGMS |
T. Rowe Price Associates, Inc. | 2,206,407 7.600% |
-164,868 (-6.95%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | The Baldwin Insurance Group, Inc. BWIN |
T. Rowe Price Associates, Inc. | 483,195 0.800% |
-4,337,240 (-89.98%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Provident Bancorp, Inc. PVBC |
T. Rowe Price Associates, Inc. | 2,445 0.000% |
-1,674,841 (-99.85%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | HashiCorp, Inc. HCP |
T. Rowe Price Associates, Inc. | 11,435,341 14.000% |
2,368,102 (+26.12%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Bill.com Holdings, Inc. BILL |
T. Rowe Price Associates, Inc. | 12,250,901 11.600% |
831,820 (+7.28%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
T. Rowe Price Associates, Inc. | 2,176,700 3.800% |
-2,206,181 (-50.34%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Sphere Entertainment Co. SPHR |
T. Rowe Price Associates, Inc. | 4,170,524 7.000% |
4,170,524 (New Position) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | MultiPlan Corporation MPLN |
T. Rowe Price Associates, Inc. | 8,062 0.100% |
-925,007 (-99.14%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
T. Rowe Price Associates, Inc. | 2,925,253 6.000% |
-1,159,545 (-28.39%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Xometry, Inc. XMTR |
T. Rowe Price Associates, Inc. | 5,164,512 11.500% |
-19,080 (-0.37%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Match Group, Inc. MTCH |
T. Rowe Price Associates, Inc. | 12,126,009 4.300% |
-2,046,205 (-14.44%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
T. Rowe Price Associates, Inc. | 3,253,736 6.900% |
-1,617,348 (-33.20%) |
Filing History |